BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 29534942)

  • 1. Revisiting the Prognostic Heterogeneity of AJCC Stage IV Carcinomas of the Upper Urinary Tract.
    Abdel-Rahman O
    Clin Genitourin Cancer; 2018 Aug; 16(4):e859-e865. PubMed ID: 29534942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the external validity of the American Joint Committee on Cancer 8th staging system for anal carcinoma.
    Oweira H; Giryes A; Mannhart M; Decker M; Schlumpf R; Abdel-Rahman O
    Curr Med Res Opin; 2018 May; 34(5):923-929. PubMed ID: 29448859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified staging system for pulmonary carcinoids on the basis of lung cancer TNM system.
    Abdel-Rahman O
    Clin Transl Oncol; 2018 May; 20(5):670-677. PubMed ID: 29022170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the AJCC 8th lung cancer staging system among patients with small cell lung cancer.
    Abdel-Rahman O
    Clin Transl Oncol; 2018 Apr; 20(4):550-556. PubMed ID: 28808860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the prognostic value of the 8th AJCC staging system for patients with clinically staged prostate cancer; A time to sub-classify stage IV?
    Abdel-Rahman O
    PLoS One; 2017; 12(11):e0188450. PubMed ID: 29182656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revisiting Dukes' paradigm; some node positive colon cancer patients have better prognosis than some node negative patients.
    Abdel-Rahman O
    Clin Transl Oncol; 2018 Jun; 20(6):794-800. PubMed ID: 29086248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the Eighth AJCC New Substages for Bladder Cancer Among Different Staging Contexts.
    Abdel-Rahman O
    Clin Genitourin Cancer; 2017 Dec; 15(6):e1095-e1106. PubMed ID: 28843376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenging a dogma; AJCC 8th staging system is not sufficient to predict outcomes of patients with malignant pleural mesothelioma.
    Abdel-Rahman O
    Lung Cancer; 2017 Nov; 113():128-133. PubMed ID: 29110839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the 8th AJCC staging system for pathologically versus clinically staged pancreatic adenocarcinoma: A time to revisit a dogma?
    Abdel-Rahman O
    Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):64-69. PubMed ID: 29428107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the 8th AJCC prognostic staging system for breast cancer in a population-based setting.
    Abdel-Rahman O
    Breast Cancer Res Treat; 2018 Feb; 168(1):269-275. PubMed ID: 29143220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the 8th AJCC staging system for gastric cancer in a population-based setting.
    Abdel-Rahman O
    Expert Rev Gastroenterol Hepatol; 2018 May; 12(5):525-530. PubMed ID: 29198151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified staging classification for intrahepatic cholangiocarcinoma based on the sixth and seventh editions of the AJCC/UICC TNM staging systems.
    Meng ZW; Pan W; Hong HJ; Chen JZ; Chen YL
    Medicine (Baltimore); 2017 Aug; 96(34):e7891. PubMed ID: 28834905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the prognostic value of new sub-stages within the AJCC 8th edition of non-small cell lung cancer.
    Abdel-Rahman O
    Clin Transl Oncol; 2017 Nov; 19(11):1414-1420. PubMed ID: 28497423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Number of positive nodes is superior to the lymph node ratio and American Joint Committee on Cancer N staging for the prognosis of surgically treated head and neck squamous cell carcinomas.
    Roberts TJ; Colevas AD; Hara W; Holsinger FC; Oakley-Girvan I; Divi V
    Cancer; 2016 May; 122(9):1388-97. PubMed ID: 26969807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revisiting the AJCC staging system of adrenocortical carcinoma.
    Abdel-Rahman O
    J Endocrinol Invest; 2022 Jan; 45(1):89-94. PubMed ID: 34170487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified the 8th AJCC staging system for patients with advanced prostate cancer: a study based on SEER database.
    Sun C; Yang D; Zhu J; Zhou Y; Xiang C; Wu S
    BMC Urol; 2022 Nov; 22(1):185. PubMed ID: 36384495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-based validation of the recursive partitioning analysis-based staging system for oropharyngeal cancer.
    Keane FK; Chen YH; Tishler RB; Schoenfeld JD; Haddad RI; Goguen LA; Catalano P; Neville BA; Margalit DN
    Head Neck; 2016 Oct; 38(10):1530-8. PubMed ID: 27080700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the prognostic and discriminating value of the novel bioscore system for breast cancer; a SEER database analysis.
    Abdel-Rahman O
    Breast Cancer Res Treat; 2017 Jul; 164(1):231-236. PubMed ID: 28417332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the American Joint Commission on Cancer (AJCC) 8th Edition Staging System for Patients with Pancreatic Adenocarcinoma: A Surveillance, Epidemiology and End Results (SEER) Analysis.
    Kamarajah SK; Burns WR; Frankel TL; Cho CS; Nathan H
    Ann Surg Oncol; 2017 Jul; 24(7):2023-2030. PubMed ID: 28213792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the external validity of the AJCC 8
    Oweira H; Abdel-Rahman O; Mehrabi A; Reissfelder C
    J Gastrointest Oncol; 2019 Jun; 10(3):421-428. PubMed ID: 31183191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.